U.S. Stock News

Why FIGS Stock Is Back on Investor Radar FIGS (FIGS) has drawn renewed attention after its second quarter 2026 earnings, higher full year revenue guidance, and an expanded share repurchase plan reset expectations around the stock. The company reported second quarter sales of US$196.62 million and net income of US$28.38 million, along with updated guidance that targets approximately 20% net revenue growth for 2026 versus 2025. FIGS also detailed recent buyback activity, including completed...

Kratos Defense & Security Solutions has delivered a very large 3-year return while its current checks still flag the stock as expensive rather than a clear bargain. Recent contract wins and program updates have kept attention on the growth story, but the valuation profile has not yet shifted into value territory. Over the past 3 years the stock has returned about 2.9x, which puts extra focus on whether the current price already reflects much of the good news. Expectations around hypersonics...

With the Federal Reserve holding rates at 3.5% to 3.75% and talking about “higher for longer,” income investors are rethinking where dividends might fit in their portfolios. Elevated borrowing costs can pressure some companies and reinforce others, which creates a real opportunity for investors who pay attention. This article walks through three dividend stocks from the screener that appear positively exposed to this rate driven backdrop. The three dividend stocks discussed next are just a...

Why Madrigal Pharmaceuticals Earnings Are Back in Focus Madrigal Pharmaceuticals (MDGL) recently reported second quarter and six month results that showed higher net losses year over year, prompting fresh attention on the stock’s financial trajectory ahead of its upcoming investor conference. See our latest analysis for Madrigal Pharmaceuticals. Madrigal Pharmaceuticals shares trade at $515.34, with a 7 day share price return of 6.92% and a year to date decline of 13.22%. The 1 year total...

Over the last 7 days, the United States market has risen by 2.2%, contributing to a remarkable 21% increase over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying undervalued stocks can offer potential opportunities for investors looking to capitalize on companies that may be trading below their intrinsic value despite strong market performance.

The United States market has shown robust performance, climbing 2.2% in the last week and rising 21% over the past year, with earnings projected to grow by 17% annually in the coming years. In such a thriving environment, growth companies with high insider ownership can be particularly appealing as they often reflect strong internal confidence and potential for sustained success.

The market has climbed 2.2% in the last 7 days and is up 21% over the past year, with earnings forecast to grow by 17% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer surprising value when built on solid financials. In this article, we explore three penny stocks that combine balance sheet strength with potential for outsized gains, offering investors a chance to discover hidden value in quality companies.

The United States market has experienced a notable uptick, rising 2.2% over the last week and 21% over the past year, with earnings projected to grow by 17% annually. In such a promising environment, identifying dividend stocks that offer both steady income and potential for capital appreciation can be an effective strategy for investors looking to bolster their portfolios.

In recent weeks, Magnolia Oil & Gas completed a US$81.4 million share repurchase tranche, issued US$500.0 million of 6.625% senior notes due 2034 to help fund its pending WildFire acquisition, reported higher second‑quarter revenue and earnings alongside increased production, and raised its quarterly dividend to US$0.18 per share. Together, these actions highlight management’s emphasis on balance sheet-funded growth, ongoing capital returns, and an operating profile that has supported higher...

In July 2026, Axogen, Inc. reported second-quarter sales of US$69.73 million and a quarterly net loss of US$1.52 million, alongside higher year-to-date losses despite stronger revenue versus the prior year. At the same time, the company raised its full-year 2026 revenue outlook to at least US$279 million, highlighting management’s increased confidence in demand for its nerve repair portfolio despite current losses. With Axogen lifting its full-year revenue guidance, we’ll now examine how...

Q1 earnings and product update set the tone for MakeMyTrip MakeMyTrip (MMYT) is back in focus after Q1 FY 2027 results, the launch of its AI travel assistant Myra 2.0, and a confidential IPO filing for subsidiary MakeMyTrip India Limited. See our latest analysis for MakeMyTrip. At a share price of US$60.91, MakeMyTrip has seen a 35.45% 90 day share price return while its 1 year total shareholder return declined 35.57%, even though the 5 year total shareholder return is 130.20%. If Q1 results...

Why Royal Gold’s latest earnings and guidance matter for investors Royal Gold (RGLD) has drawn fresh attention after reporting second quarter 2026 results and issuing detailed sales guidance for the full year. The combination gives you more current information to assess the stock. For the second quarter ended June 30, 2026, the company reported sales of US$447.1 million compared with US$207.44 million a year earlier. Net income was US$236.39 million compared with US$132.35 million in the...

Insperity earnings and guidance draw investor focus Insperity (NSP) is in the spotlight after reporting second quarter 2026 results that moved from a net loss to a net profit, alongside fresh earnings guidance for the third quarter and full year. See our latest analysis for Insperity. Following the earnings release and updated guidance, Insperity's recent share price moves have been volatile, with the share price down 2.48% over the last day and 4.49% over the past week, yet up 12.55% over 30...

Ladder Capital (LADR) drew investor attention after announcing that the sale of a Jacksonville, Florida office property is expected to contribute positively to GAAP and Distributable EPS in the third quarter of 2026. See our latest analysis for Ladder Capital. The Jacksonville sale comes as Ladder Capital’s share price has eased, with a 30 day share price return showing a 2.23% decline and a year to date decline of 13.24%, while the 5 year total shareholder return of 30.08% points to a...

Alamo Group (ALG) has drawn fresh attention after releasing second quarter 2026 results, along with amended bylaws that tighten shareholder proposal rules and clarify board practices. You now have several new data points to reassess the stock. See our latest analysis for Alamo Group. The earnings release and bylaw changes arrived after a period where Alamo Group’s recent momentum has picked up, with an 11.44% 90 day share price return. However, the 1 year total shareholder return is down...

Q2 earnings highlight sharp swing back to profit Howard Hughes Holdings (HHH) just reported second quarter 2026 results that marked a clear swing back to profit, with higher reported revenue and positive earnings replacing last year’s loss. For the quarter ended June 30, 2026, the company reported sales of US$222.43 million compared with US$111.09 million a year earlier. Reported revenue was US$1,122.33 million versus US$260.88 million for the same quarter last year. Net income for the...

In July 2026, Viking Therapeutics reported a second-quarter net loss of US$128.02 million and a six-month net loss of US$286.35 million, while simultaneously raising about US$159.59 million through multiple at-the-market follow-on common stock offerings. On the same day, the company also filed a US$500 million at-the-market follow-on offering and an omnibus shelf registration covering a wide range of securities, signaling a deliberate move to expand its financing options and balance sheet...

Hecla Mining Company has already reported its second-quarter 2026 results, with sales rising to US$333.85 million and net income reaching US$117.88 million, while also updating production guidance and maintaining quarterly dividends on both common and preferred stock. Alongside these earnings, Hecla released drilling results that extended high-grade silver mineralization at Keno Hill and uncovered new high-grade veins at Midas, underscoring how exploration progress is reshaping the company’s...

Earnings jump puts Federal Home Loan Mortgage stock back in focus Federal Home Loan Mortgage (FMCC) drew fresh attention after reporting Q2 2026 net income of US$3,838 million, compared with US$2,387 million a year earlier, alongside stronger first half figures. The company also reported net income of US$7,396 million for the first six months of 2026, compared with US$5,181 million in the same period of 2025, which gives investors updated insight into its recent profitability. See our latest...

A salmonella-linked recall at Taylor Farms has pushed food safety from the back room of the supply chain to the front page. When a company producing 40% of salad kits in the US faces questions, attention quickly shifts to the tools and services that help prevent the next incident. This article explores 3 stocks exposed to this news and how their food testing and quality control solutions might matter for your portfolio decisions. The stocks in the list below are just a starting sample, and...

With the Trump administration now openly acknowledging weak U.S. economic data and investors on edge about slowing growth, the hunt for calmer corners of the market has intensified. Periods of rising anxiety and possible policy responses can punish fragile balance sheets and reward resilience. This article walks through three low volatility stocks that appear relatively better placed against this backdrop and explains why each one might deserve a closer look right now. The stocks covered...

In late July 2026, Expro Ltd. reported second-quarter 2026 results showing lower sales and earnings year-on-year, while also completing a US$40,000,000 share repurchase program covering 2.2% of its shares. On the same day, Expro raised its full-year 2026 revenue guidance to US$1.65 billion–US$1.70 billion, reflecting contributions from the Enhanced Drilling acquisition and a geographically diverse project pipeline despite ongoing Middle East disruptions and softer expectations for its...

InterDigital earnings and guidance in focus after Q2 report InterDigital (IDCC) reported second quarter 2026 results with lower sales and earnings compared with a year earlier, while at the same time raising its full year revenue and net income guidance. The company posted second quarter sales of $260.17 million versus $300.6 million a year ago. Net income was $116.37 million compared with $180.57 million, with diluted earnings per share from continuing operations at $3.40 versus $5.35. For...

The FDA clearance of Qiagen (QGEN) QIAstat-Dx BCID GPF Plus AMR Panel for bloodstream infections, together with the company exceeding its second quarter outlook and reaffirming full year guidance, has sharpened investor focus on the stock. See our latest analysis for Qiagen. The recent QIAstat-Dx blood culture panel clearance and Q2 results appear to have coincided with a sharp shift in sentiment, with a 90 day share price return of 30.12% contrasting with a year to date share price decline...